@Linch, see the article I linked above, which identifies a bunch of specific bottlenecks where lobbying and/or targeted funding could have been really useful. I didn’t know about these when I wrote my comment above, but I claim prediction points for having a high-level heuristic that led to the right conclusion anyway.
Do you want to discuss this in a higher-bandwidth channel at some point? Eg next time we’re in an EA social or something, have an organized chat with a moderator and access to a shared monitor? I feel like we’re not engaging with each other’s arguments as much in this setting, but we can maybe clarify things better in a higher-bandwidth setting.
(No worries if you don’t want to do it; it’s not like global health is either of our day jobs)
@Linch, see the article I linked above, which identifies a bunch of specific bottlenecks where lobbying and/or targeted funding could have been really useful. I didn’t know about these when I wrote my comment above, but I claim prediction points for having a high-level heuristic that led to the right conclusion anyway.
Do you want to discuss this in a higher-bandwidth channel at some point? Eg next time we’re in an EA social or something, have an organized chat with a moderator and access to a shared monitor? I feel like we’re not engaging with each other’s arguments as much in this setting, but we can maybe clarify things better in a higher-bandwidth setting.
(No worries if you don’t want to do it; it’s not like global health is either of our day jobs)